|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1998-5-21
|
|
pubmed:abstractText |
Measurements of prothrombin fragment 1+2 (F1+2), thrombin antithrombin III complexes (TAT) and D-dimer plasma levels have been proposed as non-invasive screening tests to exclude postoperative deep venous thrombosis (DVT). We investigated the diagnostic efficacy of these coagulation activation markers to rule out postoperative DVT in patients undergoing hip surgery under antithrombotic prophylaxis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants,
http://linkedlifedata.com/resource/pubmed/chemical/Antithrombin III,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrin Fibrinogen Degradation...,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Heparin,
http://linkedlifedata.com/resource/pubmed/chemical/Hirudins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Hydrolases,
http://linkedlifedata.com/resource/pubmed/chemical/Prothrombin,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/antithrombin III-protease complex,
http://linkedlifedata.com/resource/pubmed/chemical/desirudin,
http://linkedlifedata.com/resource/pubmed/chemical/fibrin fragment D,
http://linkedlifedata.com/resource/pubmed/chemical/prothrombin fragment 1.2
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0340-6245
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
79
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
509-10
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9531030-Anticoagulants,
pubmed-meshheading:9531030-Antithrombin III,
pubmed-meshheading:9531030-Arthroplasty, Replacement, Hip,
pubmed-meshheading:9531030-Biological Markers,
pubmed-meshheading:9531030-Fibrin Fibrinogen Degradation Products,
pubmed-meshheading:9531030-Fibrinolytic Agents,
pubmed-meshheading:9531030-Heparin,
pubmed-meshheading:9531030-Hirudins,
pubmed-meshheading:9531030-Humans,
pubmed-meshheading:9531030-Peptide Fragments,
pubmed-meshheading:9531030-Peptide Hydrolases,
pubmed-meshheading:9531030-Postoperative Complications,
pubmed-meshheading:9531030-Prothrombin,
pubmed-meshheading:9531030-Recombinant Proteins,
pubmed-meshheading:9531030-Thrombophlebitis
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
|
|
pubmed:affiliation |
Institute of Internal Medicine, IRCCS Ospedale Maggiore of Milan, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
